DEPO-PROVERA

This brand name is authorized in Australia, Brazil, Canada, Ecuador, Estonia, France, Hong Kong, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug DEPO-PROVERA contains one active pharmaceutical ingredient (API):

1 Medroxyprogesterone
UNII C2QI4IOI2G - MEDROXYPROGESTERONE ACETATE

Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects.

Read about Medroxyprogesterone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
DEPO-PROVERA Suspension for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G03AC06 Medroxyprogesterone G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AC Progestogens
Discover more medicines within G03AC06
L02AB02 Medroxyprogesterone L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AB Progestogens
Discover more medicines within L02AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 3118D
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 522717100060617, 522717100060717, 522718030075303
Country: CA Health Products and Food Branch Identifier(s): 00585092
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 27.630-1-01-12
Country: EE Ravimiamet Identifier(s): 1009213, 1063550, 1063561
Country: FR Base de données publique des médicaments Identifier(s): 62429736
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 185727, 19864, 36035
Country: HK Department of Health Drug Office Identifier(s): 43794
Country: IE Health Products Regulatory Authority Identifier(s): 55581, 60088
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 3048, 42
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1090585
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 59742
Country: NL Z-Index G-Standaard Identifier(s): 14040387, 14040395
Country: NL Z-Index G-Standaard, PRK Identifier(s): 67113, 67121
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 292
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100017902, 100081219, 100257210, 100292956, 100341436
Country: SG Health Sciences Authority Identifier(s): 04540P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8681308771070
Country: US FDA, National Drug Code Identifier(s): 0009-0626, 0009-0746, 0009-4709, 0009-7376, 50090-0665
Country: ZA Health Products Regulatory Authority Identifier(s): E/21.8.2/114

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.